Sejeong Shin Selected Research

Sejeong Shin Research Topics

9	Neoplasms (Cancer) 01/2022 - 04/2005
4	Carcinoma (Carcinomatosis) 10/2019 - 04/2005
4	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2006
3	Carcinogenesis 10/2019 - 06/2006
2	Neoplasm Metastasis (Metastasis) 10/2019 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2018 - 11/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2016
1	Tuberous Sclerosis (Bourneville's Disease) 01/2016
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2016
1	Insulin Resistance 11/2011
1	Fibrosarcoma 11/2006
1	Hypoxia (Hypoxemia) 04/2005

3	Integrin alpha6beta4IBA 06/2006 - 04/2005
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 06/2006
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2017 - 01/2016
2	IntegrinsIBA 01/2012 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 11/2011 - 04/2005
1	ChromatinIBA 10/2019
1	Histone ChaperonesIBA 10/2019
1	Histones (Histone)IBA 10/2019
1	EnzymesIBA 01/2018
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	TOR Serine-Threonine KinasesIBA 08/2017
1	MTOR InhibitorsIBA 08/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2016
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2014
1	Casein Kinases (Casein Kinase)IBA 01/2014
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2011
1	Glycogen Synthase Kinase 3IBA 11/2011
1	butyl phosphorotrithioate (DEF)IBA 04/2010
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2006
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2006
1	Matrix Metalloproteinases (MMPs)IBA 11/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2006
1	isoginkgetinIBA 11/2006
1	ras ProteinsIBA 06/2006
1	Integrin beta4IBA 06/2006
1	ErbB Receptors (EGF Receptor)IBA 03/2006
1	Small Interfering RNA (siRNA)IBA 03/2006
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2005
1	TubulinIBA 04/2005
1	Glycogen Synthase Kinase 3 betaIBA 04/2005
1	Colchicine FDA LinkGeneric 04/2005

1	Drug Therapy (Chemotherapy) 01/2022
1	Therapeutics 01/2016